LLY vs VC · P/E 39, rev $22.97B vs P/E 18, rev $1.91B
Eli Lilly and Company (LLY) versus Visteon Corp (VC) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Visteon Corp (VC) is a auto parts company listed on NASDAQ.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported VC revenue for 2026-06-30 was $1.91B. Net income was $80.0M. VC currently screens at market cap $2.95B and trailing P/E 18.5.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. VC currently screens at market cap $2.95B and trailing P/E 18.5.
Not investment advice. Open the LLY and VC stock pages for the full models.
Not investment advice.